A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea
Recruiting
- Conditions
- Ulcerative Colitis
- Registration Number
- NCT06073873
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Inclusion Criteria:<br><br> - Adult participants 19 years of age or older<br><br> - Participants who will receive ozanimod according to the approved label after<br> enrollment<br><br> - Participants who sign the informed consent form voluntarily<br><br>Exclusion Criteria:<br><br> - Participants who are prescribed ozanimod for therapeutic indications not approved in<br> Korea<br><br> - Participants for whom ozanimod is contraindicated as clarified in Korean prescribing<br> information approved by Ministry of Food and Drug Safety
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse events
- Secondary Outcome Measures
Name Time Method